Institutional Ownership Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX). We have compiled data on the 410 institutions that hold shares in the stock, with a total of 283 Million shares, which have been reported (via 13F filing form) to have a value of $8.51 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
41,078,163
shares
|
$1.24 Billion
0.09% of portfolio
|
Q3 2024
Reduced 6.92%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
37,585,123
shares
|
$1.13 Billion
0.02% of portfolio
|
Q3 2024
Reduced 1.15%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
23,017,561
shares
|
$692 Million
0.01% of portfolio
|
Q2 2024
Added 8.54%
|
|
|
Baillie Gifford & CO
|
Nov 05, 2024 Q3 2024 |
16,122,491
shares
|
$485 Million
0.35% of portfolio
|
Q3 2024
Reduced 1.41%
|
|
|
Swedbank Ab
Stockholm, V7 |
Jan 23, 2025 Q4 2024 |
12,164,170
shares
|
$366 Million
0.39% of portfolio
|
Q4 2024
New holding
|
|
|
Viking Global Investors LP
|
Nov 14, 2024 Q3 2024 |
12,094,021
shares
|
$364 Million
1.32% of portfolio
|
Q3 2024
Added 1.04%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
11,899,194
shares
|
$358 Million
0.62% of portfolio
|
Q3 2024
Added 8.85%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
9,516,262
shares
|
$286 Million
0.01% of portfolio
|
Q3 2024
Added 0.31%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
7,265,786
shares
|
$219 Million
0.02% of portfolio
|
Q3 2024
Added 6.1%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
4,341,505
shares
|
$131 Million
0.06% of portfolio
|
Q3 2024
Added 84.72%
|
|
|
Amundi
Paris, I0 |
Nov 13, 2024 Q3 2024 |
3,691,255
shares
|
$111 Million
0.04% of portfolio
|
Q3 2024
Added 78.83%
|
|
|
Siguler Guff Advisers, LLC
|
Feb 15, 2023 Q4 2022 |
3,391,754
shares
|
$102 Million
64.43% of portfolio
|
Q4 2022
Reduced 49.84%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
3,112,561
shares
|
$93.6 Million
0.02% of portfolio
|
Q3 2024
Added 1.06%
|
|
|
Gmt Capital Corp
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
3,097,500
shares
|
$93.2 Million
3.57% of portfolio
|
Q3 2024
Added 27.62%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
3,033,200
shares
|
$91.2 Million
0.21% of portfolio
|
Q3 2024
Added 44.69%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
3,001,603
shares
|
$90.3 Million
0.02% of portfolio
|
Q3 2024
Added 58.12%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
2,972,201
shares
|
$89.4 Million
0.02% of portfolio
|
Q3 2024
Added 6.25%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
2,953,810
shares
|
$88.9 Million
0.01% of portfolio
|
Q3 2024
Reduced 10.42%
|
|
|
New South Capital Management Inc
Memphis, TN |
Nov 05, 2024 Q3 2024 |
2,466,371
shares
|
$74.2 Million
3.15% of portfolio
|
Q3 2024
Added 5.0%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,429,336
shares
|
$73.1 Million
0.16% of portfolio
|
Q3 2024
Added 18.07%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
2,342,260
shares
|
$70.5 Million
0.03% of portfolio
|
Q3 2024
Added 139.06%
|
|
|
Patient Capital Management, LLC
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,041,195
shares
|
$61.4 Million
3.11% of portfolio
|
Q3 2024
Added 43.3%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
2,034,705
shares
|
$61.2 Million
0.0% of portfolio
|
Q3 2024
Added 0.8%
|
|
|
Mitsubishi Ufj Trust & Banking Corp
Tokyo, M0 |
Nov 12, 2024 Q3 2024 |
2,006,306
shares
|
$60.3 Million
0.13% of portfolio
|
Q3 2024
Added 9.58%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
1,934,973
shares
|
$58.2 Million
0.08% of portfolio
|
Q3 2024
Added 15.24%
|